Abstract:Long non-coding RNAs (lncRNAs) are widely transcribed in the genome, but their expression profile and roles in colorectal cancer are not well understood. The aim of this study was to investigate the long non-coding RNA expression profile in colorectal cancer and look for potential diagnostic biomarkers of colorectal cancer. Long non-coding RNA microarray was applied to investigate the global long non-coding RNA expression profile in colorectal cancer. Gene ontology and Kyoto Encyclopedia of Genes and Genomes pathway analyses were performed using standard enrichment computational methods. The expression levels of selected long non-coding RNAs were validated by quantitative reverse transcription polymerase chain reaction. The relationship between long non-coding RNA expression levels and clinicopathological characteristics of colorectal cancer patients was assessed. Coexpression analyses were carried out to find the coexpressed genes of differentially expressed long non-coding RNAs, followed by gene ontology analysis to predict the possible role of the selected long non-coding RNAs in colorectal carcinogenesis. In this study, a total of 1596 long non-coding RNA transcripts and 1866 messenger RNA transcripts were dysregulated in tumor tissues compared with paired normal tissues. The top upregulated long non-coding RNAs in tumor tissues were CCAT1, UCA1, RP5-881L22.5, NOS2P3, and BC005081 and the top downregulated long non-coding RNAs were AK055386, AC078941.1, RP4-800J21.3, RP11-628E19.3, and RP11-384P7.7. Long non-coding RNA UCA1 was significantly upregulated in colon cancer, and AK055386 was significantly downregulated in tumor with dimension <5 cm. Functional prediction analyses showed that both the long non-coding RNAs coexpress with cell cycle related messenger RNAs. The current long non-coding RNA study provided novel insights into expression profile in colorectal cancer and predicted the potential roles of long non-coding RNAs in colorectal carcinogenesis. Among the dysregulated long non-coding RNAs, UCA1 was found to be associated with anatomic site, and AK055386 was found associated with tumor size. Further functional investigations into the molecular mechanisms are warranted to clarify the role of long non-coding RNA in colorectal carcinogenesis.

Role of long non-coding RNA in the mechanism and clinical value of gastric cancer

Emerging roles of non-coding RNAs in gastric cancer: Pathogenesis and clinical implications.

Dysregulation Of Long Non-Coding Rna In Breast Cancer: An Overview Of Mechanism And Clinical Implication

[Roles of Long Noncoding RNA in Lung Cancer].

Roles of long noncoding RNAs in gastric cancer and their clinical applications

Genome-wide Analysis of Long Non-Coding RNA Expression and Function in Colorectal Cancer

Long Non-Coding Rnas In Gastric Cancer: Versatile Mechanisms And Potential For Clinical Translation

Long non-coding RNAs: crucial regulators of gastrointestinal cancer cell proliferation

Long Non-Coding RNAs in Gastric Cancer: New Emerging Biological Functions and Therapeutic Implications

LncRNAs: emerging biomarkers in gastric cancer

Research Progress and Application Prospects of Long Noncoding RNAs in Gastric Neoplasms

Biological functions and clinical significance of long noncoding RNAs in bladder cancer

Non-coding RNAs and gastric cancer

Long Noncoding RNA: Its Partners and Their Roles in Cancer

The Molecular Roles and Clinical Implications of Non-Coding RNAs in Gastric Cancer

Focusing on long noncoding RNA dysregulation in gastric cancer

Involvement of Lncrna Dysregulation in Gastric Cancer.

Roles of Competing Endogenous RNAs in Gastric Cancer.

Long Non-Coding RNA in Gastric Cancer: Mechanisms and Clinical Implications for Drug Resistance

The Role Of Mirna And Lncrna In Gastric Cancer

Integrated Analysis Of Long Non-Coding Rnas In Human Gastric Cancer: An In Silico Study